Cramer, P., Fraser, G., Santucci-Silva, R., Grosicki, S., Dilhuydy, M., Janssens, A., Loscertales, J., Rule, S., Goy, A., Traina, S., Chan, E. K. H., Diels, J., Sengupta, N., Mahler, M., Salman, M., Howes, A., & Chanan-Khan, A. (2018). improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study. Leukemia & lymphoma, 59(9), 2075–2084. http://access.bl.uk/ark:/81055/vdc_100068804269.0x000036